Stevanato Group S.p.A. (STVN) – What Are Brokerages Saying About This Stock?

Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has received a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and two have issued a strong buy recommendation on the company.

Several analysts recently issued reports on the company. UBS Group cut their price objective on Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. William Blair lowered Stevanato Group from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Deutsche Bank started coverage on Stevanato Group in a research report on Wednesday, October 7th. They issued a “hold” rating on the stock. Weiss Ratings downgraded Stevanato Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday. Finally, Citigroup reduced their price target on Stevanato Group from $26.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, November 4th.

View Our Latest Analysis on STVN

Insider Buying and Selling

In other Stevanato Group news, Director Donald E. Morel, Jr. acquired 25,000 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The shares were purchased at an average price of €13.07 per share, with a total value of €326,750.00. Following the completion of the transaction, the director owned 62,424 shares in the company, valued at €815,881.68. The trade was a 66.80% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Mauro Stocchi sold 13,649 shares of Stevanato Group stock in a transaction that occurred on Monday, September 28th. The shares were sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the sale, the insider owned 400,000 shares of the company’s stock, valued at €8,600,000. This trade represents a 3.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of STVN. Bamco Inc. NY raised its holdings in shares of Stevanato Group by 17.4% during the 3rd quarter. Bamco Inc. NY now owns 2,927,896 shares of the company’s stock valued at $61,427,000 after purchasing an additional 433,025 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Stevanato Group by 143.9% in the 3rd quarter. Goldman Sachs Group Inc. now owns 159,129 shares of the company’s stock valued at $3,339,000 after purchasing an additional 93,880 shares during the last quarter. Freshford Capital Management LLC acquired a new stake in shares of Stevanato Group in the 3rd quarter valued at $11,149,000. GW&K Investment Management LLC boosted its holdings in Stevanato Group by 118.3% in the third quarter. GW&K Investment Management LLC now owns 6,086 shares of the company’s stock worth $128,000 after purchasing an additional 3,298 shares in the last quarter. Finally, Ieq Capital LLC bought a new stake in Stevanato Group in the third quarter worth $292,000.

Stevanato Group Trading Down 0.5%

Shares of NYSE:STVN opened at €15.85 on Friday. The firm has a fifty day moving average of €18.74 and a two-hundred day moving average of €17.91. The firm has a market capitalization of $4.80 billion, a P/E ratio of 27.33, a price-to-earnings-growth ratio of 1.58 and a beta of 0.80. Stevanato Group has a 12-month low of €12.05 and a 12-month high of €24.01. The company has a quick ratio of 1.19, a current ratio of 1.73 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing the consensus estimate of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The company had revenue of €326.06 million for the quarter. On average, equities analysts expect that Stevanato Group will post 0.67 EPS for the current fiscal year.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Further Reading

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.